The 20 references in paper А. Эрлих Д. (2014) “ДВОЙНАЯ АНТИТРОМБОЦИТАРНАЯ ТЕРАПИЯ: НЕОБХОДИМОСТЬ ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ И ВОЗМОЖНОСТИ ЕЕ ПОВЫШЕНИЯ” / spz:neicon:aterotromboz:y:2014:i:2:p:25-33

1
Libby P. The interface of atherosclerosis and thrombosis: basic mechanisms. Vasc Med, 1998, 3: 225-229.
(check this in PDF content)
2
Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol,2003, 41: 7-14.
(check this in PDF content)
3
Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation, 2003, 107: 2072-2075.
(check this in PDF content)
4
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 2011, doi:10.1093/eurheartj/ehr236.
(check this in PDF content)
5
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European Heart Journal, 2012, doi:10.1093/eurheartj/ehS215.
(check this in PDF content)
6
The Clopidogrel instable angina to prevent reccurent events trial investigators. Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001, 345: 494-502.
(check this in PDF content)
7
Wallentin L, Becker RC, Budaj A et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med2009, 361: 1045-57.
(check this in PDF content)
8
Roe MT, Armstrong PW, Fox KAA, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med2012, 367: 1297-1309.
(check this in PDF content)
9
Boggon R, van Staa TP, Timmis A et al. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction — a hospital registryprimary care cohort (MINAP-GPRD). Eur Heart J 2011, 32 (19): 2376-2386.
(check this in PDF content)
10
Эрлих А.Д., Грацианский Н.А. от имени участников регистра РЕКОРД. Результаты шестимесячного наблюдения за больными с острыми коронарными синдромами в Российском регистре РЕКОРД. Кардиология2011, 12: 11-16.
(check this in PDF content)
11
Шевченко И.И., Эрлих А.Д., Исламов Р.Р. и соавт. Сравнение данных регистров острых коронарных синдромов РЕКОРД и РЕКОРД-2: лечение и его исходы в стационарах, не имеющих возможности выполнения инвазивных коронарных процедур. Кардиология2013, 8: 4-10.
(check this in PDF content)
12
Эрлих А.Д., Мацкеплишвили С.Т., Грацианский Н.А., Бузиашвили Ю.И. и все участники московского регистра ОКС. Первый московский регистр острого коронарного синдрома: характеристика больных, лечение и исходы за время пребывания в стационаре. Кардиология 2013, 12: 4-13.
(check this in PDF content)
13
Varenhorst C, Jensevik K, Jernberg T et al. Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with actue coronary syndrome. Eur Heart J, 2013, DOI:10.1093/eurheartj/eht438. Доступно: http:// eurheartj.oxfordjournals.org.
(check this in PDF content)
14
Ho PM, Fihn SD, Wang L, et al. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J. 2007, 154(5): 846-851.
(check this in PDF content)
15
Rossini R, Capodanno D, Lettieri C et al. Prevalence, predictors and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent impantation. Am J Card 2011, 107: 186-194.
(check this in PDF content)
16
Mehran R, Baber U, Steg PG et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. The Lancet. 23, 382(9906): 1714–1722.
(check this in PDF content)
17
Park SJ, Park DW, Kim YH, et al. Duration of antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med2010, 362 (15): 1374-1382.
(check this in PDF content)
18
Lee CW, Ahn JM, Park DW, et al. Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a randomized, controlled trial. Circulation 2014, 129 (3): 304-312.
(check this in PDF content)
19
Valgimigli M, Campo G, Monti M, et al. Short- versus long-term duration of dual antiplatelet therapy after coronary stenting: a randomized multicentre trial. Circulation2012, 125 (16): 2015-2026.
(check this in PDF content)
20
Yu X, Chen F, He J, et al. Duration of dual antiplatelet therapy after implantation of the first generation and second-generation drugeluting stents. Coron Artery Dis2013, 24 (3):
(check this in PDF content)